229 related articles for article (PubMed ID: 18629498)
1. Long-term management of thrombocytosis in essential thrombocythaemia.
Birgegård G
Ann Hematol; 2009 Jan; 88(1):1-10. PubMed ID: 18629498
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic options for essential thrombocythemia and polycythemia vera.
Solberg LA
Semin Oncol; 2002 Jun; 29(3 Suppl 10):10-5. PubMed ID: 12096352
[TBL] [Abstract][Full Text] [Related]
3. Anagrelide: a review of its use in the management of essential thrombocythaemia.
Wagstaff AJ; Keating GM
Drugs; 2006; 66(1):111-31. PubMed ID: 16398570
[TBL] [Abstract][Full Text] [Related]
4. Essential thrombocythaemia in children: is a treatment needed?
Randi ML; Putti MC
Expert Opin Pharmacother; 2004 May; 5(5):1009-14. PubMed ID: 15155103
[TBL] [Abstract][Full Text] [Related]
5. Update on diagnosis and management of essential thrombocythemia.
Gisslinger H
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):430-6. PubMed ID: 16810619
[TBL] [Abstract][Full Text] [Related]
6. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.
Tefferi A
Am J Hematol; 2012 Mar; 87(3):285-93. PubMed ID: 22331582
[TBL] [Abstract][Full Text] [Related]
7. Anagrelide: new drug. Essential thrombocythaemia: further evaluation needed for this last-resort treatment.
Prescrire Int; 2006 Jun; 15(83):83-6. PubMed ID: 16764090
[TBL] [Abstract][Full Text] [Related]
8. [Primary thrombocythemia: diagnosis and therapy].
Petrides PE
Med Klin (Munich); 2006 Aug; 101(8):624-34. PubMed ID: 16896569
[TBL] [Abstract][Full Text] [Related]
9. [Treatment outcome of patients with essential thrombocythemia at our department in Hungary].
Iványi JL; Marton É; Plander M; Szendrei T
Orv Hetil; 2016 Feb; 157(9):336-41. PubMed ID: 26895801
[TBL] [Abstract][Full Text] [Related]
10. Thrombocytosis.
Schafer AI
N Engl J Med; 2004 Mar; 350(12):1211-9. PubMed ID: 15028825
[No Abstract] [Full Text] [Related]
11. Anagrelide: what was new in 2004 and 2005?
Petrides PE
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):399-408. PubMed ID: 16810615
[TBL] [Abstract][Full Text] [Related]
12. Polycythaemia vera and essential thrombocythaemia: current treatment strategies.
Penninga EI; Bjerrum OW
Drugs; 2006; 66(17):2173-87. PubMed ID: 17137402
[TBL] [Abstract][Full Text] [Related]
13. Essential thrombocythemia.
Brière JB
Orphanet J Rare Dis; 2007 Jan; 2():3. PubMed ID: 17210076
[TBL] [Abstract][Full Text] [Related]
14. How would I manage a case of essential thrombocythaemia presenting with an ischaemic toe.
McLornan D; McMullin M
Hematol Oncol; 2008 Mar; 26(1):3-7. PubMed ID: 17968848
[TBL] [Abstract][Full Text] [Related]
15. The clinical spectrum of thrombocytosis and thrombocythemia.
Frenkel EP
Am J Med Sci; 1991 Jan; 301(1):69-80. PubMed ID: 1994734
[TBL] [Abstract][Full Text] [Related]
16. Contemporary management of essential thrombocythemia in children.
Randi ML; Bertozzi I; Putti MC
Expert Rev Hematol; 2019 May; 12(5):367-373. PubMed ID: 30925843
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy of essential thrombocythaemia: economic considerations.
Griesshammer M; Langer C
Expert Opin Pharmacother; 2003 Sep; 4(9):1499-505. PubMed ID: 12943479
[TBL] [Abstract][Full Text] [Related]
18. Current treatment practice for essential thrombocythaemia in adults.
Griesshammer M; Bangerter M; Grünewald M
Expert Opin Pharmacother; 2001 Mar; 2(3):385-93. PubMed ID: 11336593
[TBL] [Abstract][Full Text] [Related]
19. Evidence and expertise in the management of polycythemia vera and essential thrombocythemia.
Finazzi G; Barbui T
Leukemia; 2008 Aug; 22(8):1494-502. PubMed ID: 18596737
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness considerations in the treatment of essential thrombocythemia.
Golub R; Adams J; Dave S; Bennett CL
Semin Oncol; 2002 Jun; 29(3 Suppl 10):28-32. PubMed ID: 12096355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]